| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/18/1994 | CA2154266A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 08/18/1994 | CA2144320A1 Therapeutic compounds derived from the neem tree |
| 08/17/1994 | EP0610499A1 Proteoglycan(g 009) effective in enhancing antitumor immunity |
| 08/17/1994 | EP0610420A1 Cell cycle controlling compositions and methods of using same |
| 08/17/1994 | EP0610322A1 Helicobacter pylori genes necessary for the regulation and maturation of urease, and use thereof |
| 08/17/1994 | EP0610286A1 Recombinant immunotoxins |
| 08/17/1994 | EP0610201A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 08/17/1994 | EP0434727A4 Red-shifted phthalocyanine and tetrabenztriazaporphyrin reagents |
| 08/17/1994 | CN1090849A Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing these compounds and .... |
| 08/17/1994 | CN1090776A Method for the safe administration of fatty acids |
| 08/17/1994 | CN1090757A Method for the safe administration of fatty acids |
| 08/17/1994 | CA2115737A1 Condensed 5-membered heterocyclic compounds, processes for preparing them and pharmaceutical compositions containing these compounds |
| 08/16/1994 | US5338874 Cis oxalato (trans 1-1,2-cyclohexanediamine) PT(II) having optically high purity |
| 08/16/1994 | US5338865 Synthesis of halichondrin B and norhalichondrin B |
| 08/16/1994 | US5338749 Treating rheumatic or arthritic disorders |
| 08/16/1994 | US5338732 Megestrol acetate formulation |
| 08/16/1994 | US5338661 Monoclonal antibody specific for a human tumour-associated antigen |
| 08/16/1994 | CA1331498C Oligopeptides with cyclic proline-analogous amino acids |
| 08/16/1994 | CA1331464C Anti-tumor method and compounds |
| 08/11/1994 | DE4404124A1 Mutierte Tumor-Nekrose-Faktor-Proteine Mutant tumor necrosis factor-proteins |
| 08/10/1994 | EP0610078A1 Cytotoxic and antiviral compound |
| 08/10/1994 | EP0610076A1 Cytotoxic compounds |
| 08/10/1994 | EP0609899A1 Derivatives of amino-ascorbic acid,the processes for their preparation and use |
| 08/10/1994 | EP0609606A1 Tucaresol as an immunopotentiatory agent |
| 08/10/1994 | EP0609437A1 Novel sphingoglycolipid and use thereof |
| 08/10/1994 | EP0609356A1 2-aminopropan-1,3-diol chemotherapeutic agents |
| 08/10/1994 | EP0609217A1 Dry starch-iodine pharmaceutical formulations |
| 08/10/1994 | EP0609211A1 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-tumor and anti-retroviral agents |
| 08/10/1994 | EP0564561A4 Peptides ketoamides, ketoacids, and ketoesters |
| 08/10/1994 | EP0555358B1 Anthracycline analogues bearing latent alkylating substituents |
| 08/10/1994 | EP0524997B1 2'-o-alkyl nucleotides and polymers containing them |
| 08/10/1994 | EP0448550B1 New derivatives of deoxy-2'-uridine substituted in the 5, 3' or 5' position by acylated alpha-amino groups, process for obtaining them and drugs containing them |
| 08/10/1994 | EP0424484B1 Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection |
| 08/10/1994 | EP0353268B1 Antitumor 6-sulfenamide, 6-sulfinamide and 6-sulfonamide purines, purine nucleosides, purine nucleotides and related compounds |
| 08/10/1994 | CN1025608C New fluoro-naphthacenediones, their glycosilatede derivatives and their manufacture procedures |
| 08/09/1994 | US5336785 Method for preparation of taxol |
| 08/09/1994 | US5336684 Oxidation products of cephalomannine |
| 08/09/1994 | US5336666 Immunostimulant drug based on polar glyopeptidolipids of mycobacterium chelonae |
| 08/09/1994 | US5336489 Treatment of allograft rejection with IL-2 receptor-specific cytotoxins |
| 08/09/1994 | CA1331419C Peptides with pharmaceutical activity |
| 08/09/1994 | CA1331382C 5-nitrobenzo [de] isoquinoline-1.3-diones, their preparation and their use |
| 08/09/1994 | CA1331345C Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth |
| 08/06/1994 | CA2088878A1 Cdnas encoding the gastrin and cck-b receptors |
| 08/04/1994 | WO1994017091A2 Foldback triplex-forming oligonucleotides |
| 08/04/1994 | WO1994017090A1 2,6-diaminopurine derivatives |
| 08/04/1994 | WO1994017076A1 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents |
| 08/04/1994 | WO1994017052A1 C2 taxane derivatives and pharmaceutical compositions containing them |
| 08/04/1994 | WO1994017051A1 Process for the preparation of baccatin iii analogs bearing new c2 and c4 functional groups |
| 08/04/1994 | WO1994017050A1 C7 taxane derivatives and pharmaceutical compositions containing them |
| 08/04/1994 | WO1994017040A1 Diarylalkyl piperidines useful as multi-drug resistant tumor agents |
| 08/04/1994 | WO1994016741A1 Immunoreactive reagents employing heterodimers |
| 08/04/1994 | WO1994016731A1 Ganglioside-klh conjugate vaccines with qs-21 |
| 08/04/1994 | WO1994016716A1 Recombinant virus immunotherapy |
| 08/04/1994 | WO1994016713A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1 |
| 08/04/1994 | WO1994016683A1 Magnetically responsive composition for carrying biologically active substances and methods of production and use |
| 08/04/1994 | WO1994013808A3 LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| 08/04/1994 | WO1994011377A3 Water soluble camptothecin derivatives |
| 08/04/1994 | WO1994009785A3 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis |
| 08/04/1994 | CA2154896A1 Immunoreactive reagents employing heterodimers |
| 08/04/1994 | CA2154468A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1 |
| 08/04/1994 | CA2154358A1 Integrated oligonucleotides |
| 08/04/1994 | CA2153688A1 2,6-diaminopurine derivatives |
| 08/04/1994 | CA2114777A1 Cytotoxic compounds |
| 08/03/1994 | EP0609032A1 Aromatic imine compounds, pharmaceutical composition thereof, useful as protein synthesis inhibitors |
| 08/03/1994 | EP0608759A2 Piperazinderivatives |
| 08/03/1994 | CN1090286A Chelans possessing ortho ligating functionality and complexes thereof |
| 08/03/1994 | CN1090272A New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 08/03/1994 | CN1090266A N-methyldeacetylcolchiceinamide derivatives |
| 08/03/1994 | CN1090174A Stabilised hexadecylphosphocholine solutions in glycerol alkyl ethers |
| 08/03/1994 | CN1090170A Novel composition based on taxoides derivative |
| 08/02/1994 | US5334767 Benzo[F]quinolinones |
| 08/02/1994 | CA1331138C Use of reverse transcriptase inhibitor for treatment of human breast carcinoma |
| 07/30/1994 | CA2114361A1 Piperazine derivatives |
| 07/27/1994 | EP0608111A1 Isolation and structure of spongistatin 1 and its use as an anti-tumor agent |
| 07/27/1994 | EP0608110A1 Isolation and structure of halistatin 2, and its use as an anti-tumor agent |
| 07/27/1994 | EP0608109A1 Isolation and structural elucidation of cephalostatin 7, 8 and 9, and their use as anti-tumor agents |
| 07/27/1994 | EP0608108A1 Isolation and structure of halistatin 1, and its use as an anti-tumor agent |
| 07/27/1994 | EP0608004A2 Human DNA in the diagnosis of retinoblastoma |
| 07/27/1994 | EP0608002A1 Optically active compounds |
| 07/27/1994 | EP0607777A2 Use of leflunomid for the inhibition of interleukin 8 |
| 07/27/1994 | EP0607776A2 Use of leflunomid for the inhibition of tumor necrosis factor alpha |
| 07/27/1994 | EP0607775A2 Use of leflunomid for the inhibition of interleukin 1 beta |
| 07/27/1994 | EP0607774A2 Use of leflunomid for the inhibition of interleukin 1 alpha |
| 07/27/1994 | EP0607647A1 N-Methyldeacetylcolchiceinamide derivatives |
| 07/27/1994 | EP0607400A1 Fluorinated 17-beta substituted-4-aza-5-alpha- andostran-3one derivatives. |
| 07/27/1994 | EP0607332A1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 07/27/1994 | EP0607309A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 07/27/1994 | EP0607206A1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 07/27/1994 | EP0580790A4 Method for potentiating primary drugs in treating multidrug resistant cells |
| 07/27/1994 | EP0406274B1 Water soluble, antineoplastic derivatives of taxol |
| 07/27/1994 | CN1089846A Anti-cancer medicine and preparation method thereof |
| 07/26/1994 | US5332856 Treatment of a dermatologic, rheumatismal, respiratory or ophthalmologic ailment |
| 07/26/1994 | US5332756 Angiogenesis inhibitor, antitumor |
| 07/26/1994 | US5332751 Antitumor |
| 07/26/1994 | US5332571 Products containing a lithium salt and a tumor necrosis factor |
| 07/26/1994 | CA2114085A1 New compounds |
| 07/26/1994 | CA1331074C Irreversible peptide ligands for bombesin receptors |
| 07/26/1994 | CA1330944C Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers |
| 07/22/1994 | CA2113739A1 Human cancer inhibitory pentapeptide amides |
| 07/21/1994 | WO1994016094A2 Recombinant anti-vla4 antibody molecules |